Cargando…
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing
IMPORTANCE: The degree of immune protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants provided by infection versus vaccination with wild-type virus remains unresolved, which could influence future vaccine strategies. The gold-standard for assessing immune protecti...
Autores principales: | O’Shea, Kelly M., Schuler, Charles F., Chen, Jesse, Troost, Jonathan P., Wong, Pamela T., Chen, Kelsea, O’Shea, Daniel R., Peng, Westley, Gherasim, Carmen, Manthei, David M., Valdez, Riccardo, Baldwin, James L., Baker, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945103/ https://www.ncbi.nlm.nih.gov/pubmed/36845123 http://dx.doi.org/10.3389/fimmu.2023.1055429 |
Ejemplares similares
-
Infection with Wild Type SARS-CoV-2 Combined with Vaccination Augments Neutralizing Antibody Levels Against Variants Including Omicron
por: O’Shea, Daniel, et al.
Publicado: (2023) -
Viral Neutralization Against SARS-CoV-2 is More Durable After Infection Versus Vaccination
por: Chen, Kelsea, et al.
Publicado: (2023) -
Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2
por: Schuler, Charles, et al.
Publicado: (2022) -
Vaccination against COVID-19 Leads to Enhanced Immunity Despite Infection History
por: O'Shea, Kelly, et al.
Publicado: (2022) -
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
por: Schuler, Charles F., et al.
Publicado: (2021)